Manmeet Soni, Chief Operating Officer at Summit Therapeutics (NASDAQ:SMMT), reported a large insider buy on October 16, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Soni purchased 2,976,190 shares of Summit Therapeutics. The total transaction amounted to $4,999,999.
Summit Therapeutics shares are trading up 6.29% at $1.86 at the time of this writing on Tuesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an investing decision, however, ...